Please try another search
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company’s lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
Name | Age | Since | Title |
---|---|---|---|
Michael F. Burgess | 60 | 2021 | Interim Chief Medical Officer & Executive Director |
Robert J. Gould | 69 | 2019 | Independent Director |
Jerel C. Davis | 47 | 2015 | Independent Chairman of the Board & Lead Independent Director |
Rishi Gupta | 47 | 2016 | Independent Director |
Malcolm K. Brenner | 72 | - | Member of Scientific Advisory Board |
William D. Waddill | 67 | 2024 | Independent Director |
Kanya Rajangam | 50 | 2021 | Independent Director |
Eric Tran | - | - | Member of the Scientific Advisory Board |
James J. Mule | 71 | - | Member of the Scientific Advisory Board |
Alan Melcher | - | - | Member of the Scientific Advisory Board |
Bernard A. Fox | 70 | - | Member of the Scientific Advisory Board |
Jeffrey S. Weber | - | 2023 | Member of the Scientific Advisory Board |
Adrian Hill | - | - | Member of the Scientific Advisory Board |
Robert A. Seder | - | - | Member of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review